To calculate the signature score, we used a gene list of breast cancer-specific FOXA1 or ER targets with positive expression correlations of each TF and its target genes as well as a regulatory potential of ≥0.5 in Cistrome Cancer33. This evidence concerns the gene TF and breast carcinoma.